8-K - HR - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 16, 2024 (February 16, 2024)

Healthcare Realty Trust Incorporated

(Exact name of registrant as specified in its charter)

	Maryland	(Healthcare Realty Trust Incorporated)	001-35568	20-4738467
(State or other jurisdiction of incorporation or organization)			(Commission File Number)	(I.R.S. Employer Identification No.)
3310 West End Avenue, Suite 700	Nashville,	Tennessee	37203		(615)	269-8175
---	---	---	---	---	---	---
(Address of Principal Executive Office and Zip Code)				(Registrant’s telephone number, including area code)
www.healthcarerealty.com
---
(Internet address)

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Class A Common Stock, $0.01 par value per share	HR	New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Healthcare Realty Trust Incorporated	☐	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Healthcare Realty Trust Incorporated	☐
Item 2.02	Results of Operations and Financial Condition.
---	---

Fourth Quarter Earnings Press Release

On February 16, 2024, Healthcare Realty Trust Incorporated (the “Company”) issued a press release announcing its earnings for the fourth quarter ended December 31, 2023. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.

Item 7.01	Regulation FD Disclosure

Fourth Quarter Supplemental Information

The Company is furnishing its Supplemental Information for the fourth quarter ended December 31, 2023, which is also contained on its website (www.healthcarerealty.com). See Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01	Financial Statements and Exhibits.

(d) Exhibits.

99.1	Fourth quarter earnings press release, dated February 16, 2024.
99.2	Supplemental Information for the fourth quarter ended December 31, 2023.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Healthcare Realty Trust Incorporated
Date: February 16, 2024	By:	/s/ J. Christopher Douglas
		Name: J. Christopher Douglas
		Title: Executive Vice President - Chief Financial Officer

Document

Ron Hubbard

Vice President, Investor Relations

P: 615.269.8290

News Release

HEALTHCARE REALTY TRUST REPORTS RESULTS FOR THE FOURTH QUARTER

NASHVILLE, Tennessee, February 16, 2024 - Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December 31, 2023. The Company reported net income (loss) attributable to common stockholders of $(40.5) million, or $(0.11) per diluted common share, for the quarter ended December 31, 2023. Normalized FFO for the three months ended December 31, 2023 totaled $150.7 million, or $0.39 per diluted common share.

The following applies to all same store disclosures reported in this press release. Subsequent to its merger with Healthcare Trust of America ("Legacy HTA") on July 20, 2022, the Company began reporting combined same store results in the third quarter of 2022, which are now referred to as Merger Combined Same Store. Merger Combined Same Store includes the Company’s same store properties, including Legacy HTA properties, that were owned for the full comparative period, and that meet all elements of the Company’s same store criteria. The Company presents the combined companies’ same store portfolios to provide an understanding of the operating performance and growth potential of the combined company.

RESULTS

•Net (loss) income attributable to common stockholders for the three months ended December 31, 2023 was $(40.5) million or $(0.11) per diluted common share. Net (loss) income attributable to common stockholders for the year ended December 31, 2023 was $(278.3) million or $(0.74) per diluted common share.

•Normalized FFO per share totaled $0.39 and $1.57 for the three months and year ended December 31, 2023, respectively.

MERGER COMBINED SAME STORE

•Merger Combined Same Store cash NOI for the fourth quarter increased 2.7% over the prior year, and 2.8% for the year ended December 31, 2023.

•Fourth quarter predictive growth measures in the Merger Combined Same Store portfolio include:

◦Average in-place rent increases of 2.8%

◦Future annual contractual increases of 2.9% for leases commencing in the quarter.

◦Weighted average MOB cash leasing spreads of 3.3% on 607,000 square feet renewed:

▪3% (<0% spread)

▪6% (0-3%)

▪76% (3-4%)

HEALTHCAREREALTY.COM	PAGE 1 OF 9

▪16% (>4%)

◦Tenant retention of 78.2%

MULTI-TENANT OCCUPANCY AND ABSORPTION

•During the quarter, the multi-tenant portfolio had sequential occupancy improvement of 175,000 square feet, or 53 basis points.

	4Q 2023
(in thousands, except % and bps)	NOVEMBER 2023 PROJECTION		ACTUAL
Total multi-tenant SF	33,552		33,371
Starting occupancy	85.1	%	84.7	%
Absorption (SF)	120-180		175
Ending occupancy	85.4-85.6%		85.2	%
Change in occupancy (bps)	+ 30-50		+ 53

•Total multi-tenant square feet changes from the November 2023 projection to 4Q 2023 actual include the sale of properties comprising 287,000 square feet offset by a 106,000 square feet development completion.

•The multi-tenant portfolio leased percentage was 87.3% at December 31, which was 210 basis points greater than occupancy.

◦The multi-tenant Legacy HTA portfolio leased percentage was 85.5%, which was 230 basis points greater than occupancy.

•An updated multi-tenant occupancy and NOI bridge can be found on page 21 of the Investor Presentation.

LEASING

•Portfolio leasing activity that commenced in the fourth quarter totaled 1,224,000 square feet related to 340 leases:

◦703,000 square feet of renewals

◦508,000 square feet of new and 13,000 square feet of expansion leases

•The Company executed new leases totaling 425,000 square feet in the quarter that will commence in future periods.

DISPOSITIONS

•During the fourth quarter, the Company sold 27 properties totaling $338 million.

•Additional dispositions in 2023 totaled 36 properties for $656 million at an average cap rate of 6.6%. These dispositions generated proceeds of $597 million and $59 million of seller financing.

HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 2 OF 9

•The 2023 additional dispositions do not include the January 2023 dispositions of $112 million to repay the balance on the asset sale term loan.

•The 2023 total dispositions improved the quality and growth profile of the portfolio as seen through the following characteristics:

◦34% non-MOB

◦54% off campus MOB

◦63% single-tenant

◦1.9% average in-place escalators

BALANCE SHEET

•Net debt to adjusted EBITDA was 6.4 times at the end of the quarter.

•During the fourth quarter, the Company executed interest rate swaps totaling $275 million. In January 2024, $200 million of interest rate swaps expired.

•As of December 31, 2023, including the effect of the expiration of the January 2024 interest rate swap, variable rate debt was 8%. This reflects an improvement from 13% as of December 31, 2022.

•As of December 31, 2023, the Company's line of credit balance was fully repaid.

DIVIDEND

•A dividend of $0.31 per share was paid in November 2023. A dividend of $0.31 per share will be paid on March 14, 2024 to stockholders and OP unitholders of record on February 26, 2024.

EARNINGS CALL

•On Friday, February 16, 2024, at 11:00 a.m. Eastern Time, Healthcare Realty Trust has scheduled a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends.

•Simultaneously, a webcast of the conference call will be available to interested parties at https://investors.healthcarerealty.com/corporate-profile/webcasts under the Investor Relations section. A webcast replay will be available following the call at the same address.

•Live Conference Call Access Details:

◦Domestic Dial-In Number: +1 404-975-4839 access code 926364;

◦All Other Locations: +1 833-470-1428 access code 926364.

•Replay Information:

◦Domestic Dial-In Number: +1 929-458-6194 access code 512784;

◦All Other Locations: +1 866-813-9403 access code 512784.

HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 3 OF 9
GUIDANCE
---

•The Company's 2024 guidance range represents the in-place portfolio as of February 16, 2024, and does not include any assumptions for prospective acquisitions, joint venture seed portfolios or other related balance sheet activities that have not closed unless otherwise noted. The 2024 guidance range expectations are as follows:

	ACTUAL		EXPECTED 1Q 2024		EXPECTED 2024
	4Q 2023	2023	LOW	HIGH	LOW	HIGH
Earnings per share	$(0.11)	$(0.74)	$(0.12)	$(0.11)	$(0.60)	$(0.10)
NAREIT FFO per share	$0.36	$1.43	$0.35	$0.36	$1.42	$1.48
Normalized FFO per share	$0.39	$1.57	$0.38	$0.39	$1.52	$1.58

•The 2024 annual guidance above includes the following significant changes from 2023 results (dollars in thousands, except per share data). Refer to page 28 for additional guidance detail including operating metrics and capital funding expectations.

4Q 2023 RUN-RATE NORMALIZED FFO RECONCILIATION
4Q 2023 normalized FFO
Non-recurring items		(4,730)
4Q 2023 run-rate normalized FFO		146,000
		EXPECTED 2024
KEY ASSUMPTIONS		LOW
Annualized 4Q 2023 run-rate normalized FFO		584,000
Multi-tenant cash NOI		21,000
Single-tenant cash NOI		1,000
Straight-line rent		(2,000)
Performance based compensation		(5,500)
Interest rate swap maturity		(6,500)
Re/development and other capital funding		(7,500)
Other		—
Expected normalized FFO		584,500
Expected normalized FFO per share	$1.52	1.58

All values are in US Dollars.

The 2024 annual guidance range reflects the Company's view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, interest rates, and operating and general and administrative expenses. The Company's guidance does not contemplate impacts from gains or losses from

dispositions, potential impairments, or debt extinguishment costs, if any. There can be no assurance that the Company's actual results will not be materially higher or lower than these expectations. If actual results vary from these assumptions, the Company's expectations may change.

HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 4 OF 9

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes nearly 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. In addition to the historical information contained within, this press release contains certain forward-looking statements with respect to the Company. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management’s intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: the Company's expected results may not be achieved; failure to realize the expected benefits of the Merger; significant transaction costs and/or unknown or inestimable liabilities; the risk that HTA’s business will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; general adverse economic and local real estate conditions; changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in the Company’s proposed market areas; changes in accounting principles generally accepted in the US; policies and guidelines applicable to REITs; the availability of properties to acquire; the availability of financing; pandemics and other health concerns, and the measures intended to prevent their spread, including the currently ongoing COVID-19 pandemic; and the potential material adverse effect these matters may have on the Company’s business, results of operations, cash flows and financial condition. Additional information concerning the Company and its business, including additional factors that could materially and adversely affect the Company’s financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in the Company’s 2023 Annual Report on Form 10-K and in its other filings with the SEC.

HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 5 OF 9
Consolidated Balance Sheets
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA		ASSETS
---	---	---	---	---	---
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Real estate properties
Land	$1,343,265	$1,387,821	$1,424,453	$1,412,805	$1,439,798
Buildings and improvements	10,881,373	11,004,195	11,188,821	11,196,297	11,332,037
Lease intangibles	836,302	890,273	922,029	929,008	959,998
Personal property	12,718	12,686	12,615	11,945	11,907
Investment in financing receivables, net	122,602	120,975	121,315	120,692	120,236
Financing lease right-of-use assets	82,209	82,613	83,016	83,420	83,824
Construction in progress	60,727	85,644	53,311	42,615	35,560
Land held for development	59,871	59,871	78,411	69,575	74,265
Total real estate investments	13,399,067	13,644,078	13,883,971	13,866,357	14,057,625
Less accumulated depreciation and amortization	(2,226,853)	(2,093,952)	(1,983,944)	(1,810,093)	(1,645,271)
Total real estate investments, net	11,172,214	11,550,126	11,900,027	12,056,264	12,412,354
Cash and cash equivalents	25,699	24,668	35,904	49,941	60,961
Assets held for sale, net	8,834	57,638	151	3,579	18,893
Operating lease right-of-use assets	275,975	323,759	333,224	336,112	336,983
Investments in unconsolidated joint ventures	311,511	325,453	327,245	327,746	327,248
Other assets, net and goodwill	842,898	822,084	797,796	795,242	693,192
Total assets	$12,637,131	$13,103,728	$13,394,347	$13,568,884	$13,849,631
LIABILITIES AND STOCKHOLDERS' EQUITY
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Liabilities
Notes and bonds payable	$4,994,859	$5,227,413	$5,340,272	$5,361,699	$5,351,827
Accounts payable and accrued liabilities	211,994	204,947	196,147	155,210	244,033
Liabilities of properties held for sale	295	3,814	222	277	437
Operating lease liabilities	229,714	273,319	278,479	279,637	279,895
Financing lease liabilities	74,503	74,087	73,629	73,193	72,939
Other liabilities	202,984	211,365	219,694	232,029	218,668
Total liabilities	5,714,349	5,994,945	6,108,443	6,102,045	6,167,799
Redeemable non-controlling interests	3,868	3,195	2,487	2,000	2,014
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized	—	—	—	—	—
Common stock, $0.01 par value; 1,000,000 shares authorized	3,810	3,809	3,808	3,808	3,806
Additional paid-in capital	9,602,592	9,597,629	9,595,033	9,591,194	9,587,637
Accumulated other comprehensive (loss) income	(10,741)	17,079	9,328	(8,554)	2,140
Cumulative net income attributable to common stockholders	1,028,794	1,069,327	1,137,171	1,219,930	1,307,055
Cumulative dividends	(3,801,793)	(3,684,144)	(3,565,941)	(3,447,750)	(3,329,562)
Total stockholders' equity	6,822,662	7,003,700	7,179,399	7,358,628	7,571,076
Non-controlling interest	96,252	101,888	104,018	106,211	108,742
Total Equity	6,918,914	7,105,588	7,283,417	7,464,839	7,679,818
Total liabilities and stockholders' equity	$12,637,131	$13,103,728	$13,394,347	$13,568,884	$13,849,631
HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 6 OF 9
---	---
Consolidated Statements of Income
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
	THREE MONTHS ENDED DECEMBER 31,		TWELVE MONTHS ENDED DECEMBER 31,
---	---	---	---	---
	2023	2022	2023	2022
Revenues
Rental income	$322,076	$329,399	$1,309,184	$907,451
Interest income	4,422	4,227	17,134	11,480
Other operating	3,943	4,436	17,451	13,706
	330,441	338,062	1,343,769	932,637
Expenses
Property operating	121,362	117,009	500,437	344,038
General and administrative	14,609	14,417	58,405	52,734
Normalizing items 1	(1,445)	—	(1,720)	—
Normalized general and administrative	13,164	14,417	56,685	52,734
Acquisition and pursuit costs 2	301	92	2,026	3,229
Merger-related costs	1,414	10,777	(1,952)	103,380
Depreciation and amortization	180,049	185,275	730,709	453,082
	317,735	327,570	1,289,625	956,463
Other income (expense)
Interest expense before merger-related fair value	(52,387)	(52,464)	(215,699)	(125,443)
Merger-related fair value adjustment	(10,800)	(11,979)	(42,885)	(21,248)
Interest expense	(63,187)	(64,443)	(258,584)	(146,691)
Gain on sales of real estate properties	20,573	73,083	77,546	270,271
Gain (loss) on extinguishment of debt	—	119	62	(2,401)
Impairment of real estate assets and credit loss reserves	(11,403)	(54,452)	(154,912)	(54,427)
Equity (loss) gain from unconsolidated joint ventures	(430)	89	(1,682)	(687)
Interest and other income (expense), net	65	(1,168)	1,343	(1,546)
	(54,382)	(46,772)	(336,227)	64,519
Net (loss) income	$(41,676)	$(36,280)	$(282,083)	$40,693
Net loss (income) attributable to non-controlling interests	1,143	516	3,822	204
Net (loss) income attributable to common stockholders	$(40,533)	$(35,764)	$(278,261)	$40,897
Basic earnings per common share	$(0.11)	$(0.10)	$(0.74)	$0.15
Diluted earnings per common share	$(0.11)	$(0.10)	$(0.74)	$0.15
Weighted average common shares outstanding - basic	379,044	378,617	378,928	252,356
Weighted average common shares outstanding - diluted 3	379,044	378,617	378,928	253,873

14Q 2023 normalizing items include severance costs and YTD 2023 includes severance costs and non-routine legal costs.

2Includes third party and travel costs related to the pursuit of acquisitions and developments.

3Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount. As a result, the Company's OP totaling 3,966,365 units was not included.

HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 7 OF 9
Reconciliation of FFO, Normalized FFO and FAD 1,2,3
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
	THREE MONTHS ENDED DECEMBER 31,		TWELVE MONTHS ENDED DECEMBER 31,
---	---	---	---	---
	2023	2022	2023	2022
Net (loss) income attributable to common stockholders	$(40,533)	$(35,764)	$(278,261)	$40,897
Net loss attributable to common stockholders/diluted share 3	$(0.11)	$(0.10)	$(0.74)	$0.15
Gain on sales of real estate assets	(20,573)	(73,083)	(77,546)	(270,271)
Impairments of real estate assets	11,403	54,452	149,717	54,427
Real estate depreciation and amortization	182,272	186,658	738,526	459,211
Non-controlling loss from partnership units	(491)	(382)	(3,426)	(5)
Unconsolidated JV depreciation and amortization	4,442	4,020	18,116	12,722
FFO adjustments	$177,053	$171,665	$825,387	$256,084
FFO adjustments per common share - diluted	$0.46	$0.45	$2.15	$1.01
FFO	$136,520	$135,901	$547,126	$296,981
FFO per common share - diluted	$0.36	$0.35	$1.43	$1.17
Acquisition and pursuit costs	301	92	2,026	3,229
Merger-related costs	1,414	10,777	(1,952)	103,380
Lease intangible amortization	261	137	860	1,028
Non-routine legal costs/forfeited earnest money received	(100)	194	175	771
Debt financing costs	—	625	(62)	3,145
Severance costs	1,445	—	1,445	—
Allowance for credit losses 4	—	—	8,599	—
Merger-related fair value adjustment	10,800	11,979	42,885	21,248
Unconsolidated JV normalizing items 5	89	96	389	330
Normalized FFO adjustments	$14,210	$23,900	$54,365	$133,131
Normalized FFO adjustments per common share - diluted	$0.04	$0.06	$0.14	$0.52
Normalized FFO	$150,730	$159,801	$601,491	$430,112
Normalized FFO per common share - diluted	$0.39	$0.42	$1.57	$1.69
Non-real estate depreciation and amortization	685	624	2,566	2,217
Non-cash interest amortization, net 6	1,265	2,284	4,968	5,129
Rent reserves, net	1,404	(100)	3,163	516
Straight-line rent income, net	(7,872)	(9,873)	(32,592)	(20,124)
Stock-based compensation	3,566	3,573	13,791	14,294
Unconsolidated JV non-cash items 7	(206)	(316)	(1,034)	(1,206)
Normalized FFO adjusted for non-cash items	149,572	155,993	592,353	430,938
2nd generation TI	(18,715)	(13,523)	(66,081)	(33,620)
Leasing commissions paid	(14,978)	(7,404)	(36,391)	(22,929)
Capital expenditures	(17,393)	(25,669)	(49,343)	(48,913)
Total maintenance capex	(51,086)	(46,596)	(151,815)	(105,462)
FAD	$98,486	$109,397	$440,538	$325,476
Quarterly/annual dividends	$118,897	$119,323	$477,239	$285,774
FFO wtd avg common shares outstanding - diluted 8	383,326	383,228	383,381	254,622

1Funds from operations (“FFO”) and FFO per share are operating performance measures adopted by NAREIT. NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.”

2FFO, Normalized FFO and Funds Available for Distribution ("FAD") do not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered alternatives to net income attributable to common stockholders as indicators of the Company's operating performance or as alternatives to cash flow as measures of liquidity.

3Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.

4In Q1 2023, allowance for credit losses included a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Income and $3.4 million reserve included in “Rental Income” on the Statement of Income for previously deferred rent and straight line rent for three skilled nursing facilities.

5Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.

6Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.

7Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.

8The Company utilizes the treasury stock method, which includes the dilutive effect of nonvested share-based awards outstanding of 308,389 for the three months ended December 31, 2023. Also includes the diluted impact of 3,966,365 OP units outstanding.

HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 8 OF 9
Reconciliation of Non-GAAP Measures
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA - UNAUDITED

Management considers funds from operations ("FFO"), FFO per share, normalized FFO, normalized FFO per share, funds available for distribution ("FAD") to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors.

The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.

FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts, Inc. (“NAREIT”). NAREIT defines FFO as “net income (computed in accordance with GAAP) excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control, and impairment write-downs of certain real assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity.” The Company defines Normalized FFO as FFO excluding acquisition-related expenses, lease intangible amortization and other normalizing items that are unusual and infrequent in nature. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, deferred financing fees amortization, share-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, Normalized FFO and FAD should not be considered an alternative to net income as an indicator of the Company’s operating performance or as an alternative to cash flow as a measure of liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.

Management believes FFO, FFO per share, Normalized FFO, Normalized FFO per share, and FAD provide an understanding of the operating performance of the Company’s properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, Normalized FFO per share and FAD can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs.

Merger Combined Cash NOI and Merger Combined Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Merger Combined Cash NOI as rental income and less property operating expenses. Merger Combined Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, lease termination fees, tenant improvement amortization and leasing commission amortization. Merger Combined Cash NOI is historical and not necessarily indicative of future results.

Merger Combined Same Store Cash NOI compares Merger Combined Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties.

The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.

Any recently acquired property will be included in the same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the same store pool eight full quarters after substantial completion.

HEALTHCARE REALTY TRUST INCORPORATED	HEALTHCAREREALTY.COM	PAGE 9 OF 9

Document

4Q2023
Supplemental Information
FURNISHED AS OF FEBRUARY 16, 2024 - UNAUDITED
FORWARD LOOKING STATEMENTS & RISK FACTORS
---

This Supplemental Information report contains disclosures that are “forward-looking statements” as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words and phrases such as “can,” “may,” “payable,” “indicative,” "predictive," “annualized,” “expect,” “expected,” “range of expectations,” "would have been," "budget," and other comparable terms in this report, and include, but are not limited to, statements related to the merger between Healthcare Realty Trust Incorporated (“Legacy HR” and, after the closing of the merger, the “Company” or "HR") and Healthcare Trust of America, Inc. (“HTA”) that closed on July 20, 2022 (the “Merger”). These forward-looking statements are made as of the date of this report and are not necessarily indicative of future performance. These statements are based on the current plans and expectations of Company management and are subject to a number of unknown risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those described in this release or implied by such forward-looking statements. Such risks and uncertainties include, among other things, the following: the Company’s expected results may not be achieved; failure to realize the expected benefits of the Merger; the risk that the Company’s and HTA’s respective businesses will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company’s common stock could decline; pandemics or other health crises, such as COVID-19; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; and other legal and operational matters. Other risks, uncertainties and factors that could cause actual results to differ materially from those projected are detailed under the heading “Risk Factors,” in the Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) for the year ended December 31, 2023, under the heading "Risk Factors" and other risks described from time to time thereafter in the Company's SEC filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

| Table of Contents | | --- || 4 | Highlights | | --- | --- | | 7 | Salient Facts | | 8 | Corporate Information | | 9 | Balance Sheet | | 10 | Statements of Income | | 11 | FFO, Normalized FFO, & FAD | | 12 | Capital Funding & Commitments | | 13 | Debt Metrics | | 14 | Debt Covenants & Liquidity | | 15 | Investment Activity | | 16 | Re/development Activity | | 17 | Portfolio | | 18 | Health Systems | | 19 | MOB Proximity to Hospital | | 20 | Lease Maturity & Occupancy | | 21 | Leasing Statistics | | 22 | Merger Combined Same Store | | 24 | NOI Reconciliations | | 26 | EBITDA Reconciliations | | 27 | Components of Net Asset Value | | 28 | Components of Expected FFO | | HEALTHCARE REALTY | 4Q 2023 SUPPLEMENTAL INFORMATION 3 | | --- | --- | | Highlights | | --- |

The following applies to all same store disclosures reported in this supplemental report. Subsequent to its merger with Healthcare Trust of America ("Legacy HTA") on July 20, 2022, the Company began reporting combined same store results in the third quarter of 2022, which are now referred to as Merger Combined Same Store. Merger Combined Same Store includes the Company’s same store properties, including Legacy HTA properties, that were owned for the full comparative period, and that meet all elements of the Company’s same store criteria. The Company presents the combined companies’ same store portfolios to provide an understanding of the operating performance and growth potential of the combined company.

NET INCOME AND NORMALIZED FFO

•Normalized FFO per share totaled $0.39 and $1.57 for the three months and year ended December 31, 2023, respectively.

MERGER COMBINED SAME STORE

•Merger Combined Same Store cash NOI for the fourth quarter increased 2.7% over the prior year, and 2.8% for the year ended December 31, 2023.

•Fourth quarter predictive growth measures in the Merger Combined Same Store portfolio include:

◦Average in-place rent increases of 2.8%

◦Future annual contractual increases of 2.9% for leases commencing in the quarter.

◦Weighted average MOB cash leasing spreads of 3.3% on 607,000 square feet renewed:

▪3% (<0% spread)

▪6% (0-3%)

▪76% (3-4%)

▪16% (>4%)

◦Tenant retention of 78.2%

MULTI-TENANT OCCUPANCY AND ABSORPTION

•During the quarter, the multi-tenant portfolio had sequential occupancy improvement of 175,000 square feet, or 53 basis points.

	4Q 2023
(in thousands, except % and bps)	NOVEMBER 2023 PROJECTION		ACTUAL
Total multi-tenant SF	33,552		33,371
Starting occupancy	85.1	%	84.7	%
Absorption (SF)	120-180		175
Ending occupancy	85.4-85.6%		85.2	%
Change in occupancy (bps)	+ 30-50		+ 53

•The multi-tenant portfolio leased percentage was 87.3% at December 31, which was 210 basis points greater than occupancy.

◦The multi-tenant Legacy HTA portfolio leased percentage was 85.5%, which was 230 basis points greater than occupancy.

•An updated multi-tenant occupancy and NOI bridge can be found on page 21 of the Investor Presentation.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 4
Highlights
---		LEASING
---

•Portfolio leasing activity that commenced in the fourth quarter totaled 1,224,000 square feet related to 340 leases:

◦703,000 square feet of renewals

◦508,000 square feet of new and 13,000 square feet of expansion leases

•The Company executed new leases totaling 425,000 square feet in the quarter that will commence in future periods.

DISPOSITIONS

•During the fourth quarter, the Company sold 27 properties totaling $338 million.

•Additional dispositions in 2023 totaled 36 properties for $656 million at an average cap rate of 6.6%. These dispositions generated proceeds of $597 million and $59 million of seller financing.

•The 2023 additional dispositions do not include the January 2023 dispositions of $112 million to repay the balance on the asset sale term loan.

•The 2023 total dispositions improved the quality and growth profile of the portfolio as seen through the following characteristics:

◦34% non-MOB

◦54% off campus MOB

◦63% single-tenant

◦1.9% average in-place escalators

BALANCE SHEET

•Net debt to adjusted EBITDA was 6.4 times at the end of the quarter.

•During the fourth quarter, the Company executed interest rate swaps totaling $275 million. In January 2024, $200 million of interest rate swaps expired.

•As of December 31, 2023, including the effect of the expiration of the January 2024 interest rate swap, variable rate debt was 8%. This reflects an improvement from 13% as of December 31, 2022.

•As of December 31, 2023, the Company's line of credit balance was fully repaid.

DIVIDEND

•A dividend of $0.31 per share was paid in November 2023. A dividend of $0.31 per share will be paid on March 14, 2024 to stockholders and OP unitholders of record on February 26, 2024.

EARNINGS CALL

•Live Conference Call Access Details:

◦Domestic Dial-In Number: +1 404-975-4839 access code 926364;

◦All Other Locations: +1 833-470-1428 access code 926364.

•Replay Information:

◦Domestic Dial-In Number: +1 929-458-6194 access code 512784;

◦All Other Locations: +1 866-813-9403 access code 512784.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 5
Highlights
---		GUIDANCE
---

	ACTUAL		EXPECTED 1Q 2024		EXPECTED 2024
	4Q 2023	2023	LOW	HIGH	LOW	HIGH
Earnings per share	$(0.11)	$(0.74)	$(0.12)	$(0.11)	$(0.60)	$(0.10)
NAREIT FFO per share	$0.36	$1.43	$0.35	$0.36	$1.42	$1.48
Normalized FFO per share	$0.39	$1.57	$0.38	$0.39	$1.52	$1.58

4Q 2023 RUN-RATE NORMALIZED FFO RECONCILIATION
4Q 2023 normalized FFO
Non-recurring items		(4,730)
4Q 2023 run-rate normalized FFO		146,000
		EXPECTED 2024
SIGNIFICANT YEAR-OVER-YEAR CHANGES		LOW
Annualized 4Q 2023 run-rate normalized FFO		584,000
Multi-tenant cash NOI		21,000
Single-tenant cash NOI		1,000
Straight-line rent		(2,000)
Performance based compensation		(5,500)
Interest rate swap maturity		(6,500)
Re/development and other capital funding		(7,500)
Other		—
Expected normalized FFO		584,500
Expected normalized FFO per share	$1.52	1.58

All values are in US Dollars.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 6
Salient Facts 1
---
AS OF DECEMBER 31, 2023
Properties
---
688 properties totaling 40.3M SF
69 markets in 35 states
93% managed by Healthcare Realty
93% outpatient medical facilities
60% of NOI in Top 15 Markets
Capitalization
$11.9B enterprise value as of 12/31/23
$6.6B market capitalization as of 12/31/23
384.8M shares outstanding (including OP units)
$0.31 quarterly dividend per share
BBB/Baa2 S&P/Moody's
44.2% net debt to enterprise value at 12/31/23
6.4x net debt to adjusted EBITDA

1 Includes properties held in joint ventures.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 7
Corporate Information
---

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As of December 31, 2023, the Company was invested in 688 real estate properties in 35 states totaling 40.3 million square feet and had an enterprise value of approximately $11.9 billion, defined as equity market capitalization plus the principal amount of debt less cash. The Company provided leasing and property management services to 93% of its portfolio.

EXECUTIVE OFFICERS
Todd J. Meredith
President and Chief Executive Officer
John M. Bryant, Jr.
Executive Vice President and General Counsel
J. Christopher Douglas
Executive Vice President and Chief Financial Officer
Robert E. Hull
Executive Vice President - Investments
Julie F. Wilson
Executive Vice President - Operations
ANALYST COVERAGE
---
BMO Capital Markets
BTIG, LLC
Citi Research
Deutsche Bank Securities
Green Street Advisors, Inc.
J.P. Morgan Securities LLC
Jefferies LLC
KeyBanc Capital Markets Inc.
Raymond James & Associates
Scotiabank
Stifel, Nicolaus & Company, Inc.
Wedbush Securities
Wells Fargo Securities, LLC
BOARD OF DIRECTORS
---

J. Knox Singleton

Chairman, Healthcare Realty Trust Incorporated

Retired Chief Executive Officer, Inova Health System

W. Bradley Blair, II

Vice Chairman, Healthcare Realty Trust Incorporated

Retired Chairman, Healthcare Trust of America

Todd J. Meredith

President and Chief Executive Officer

Healthcare Realty Trust Incorporated

John V. Abbott

Retired Chief Executive Officer

Aviation Asset Management Group, General Electric Company

Nancy H. Agee

President and Chief Executive Officer

Carilion Clinic

Vicki U. Booth

President and Board Chair

Ueberroth Family Foundation

Edward H. Braman

Retired Audit Partner

Ernst & Young LLP

Ajay Gupta

Chief Executive Officer

Physician Rehabilitation Network

James J. Kilroy

President and Portfolio Manager

Willis Investment Counsel

Jay P. Leupp

Managing Partner and Senior Portfolio Manager

Terra Firma Asset Management, LLC

Peter F. Lyle

Executive Vice President

Medical Management Associates, Inc.

Constance B. Moore

Retired President and CEO

BRE Properties, Inc.

Christann M. Vasquez

Retired Healthcare Executive

David R. Emery (1944-2019)

Chairman Emeritus

Healthcare Realty Trust Incorporated

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 8
Balance Sheet
---
AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA		ASSETS
---	---	---	---	---	---
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Real estate properties
Land	$1,343,265	$1,387,821	$1,424,453	$1,412,805	$1,439,798
Buildings and improvements	10,881,373	11,004,195	11,188,821	11,196,297	11,332,037
Lease intangibles	836,302	890,273	922,029	929,008	959,998
Personal property	12,718	12,686	12,615	11,945	11,907
Investment in financing receivables, net	122,602	120,975	121,315	120,692	120,236
Financing lease right-of-use assets	82,209	82,613	83,016	83,420	83,824
Construction in progress	60,727	85,644	53,311	42,615	35,560
Land held for development	59,871	59,871	78,411	69,575	74,265
Total real estate investments	13,399,067	13,644,078	13,883,971	13,866,357	14,057,625
Less accumulated depreciation and amortization	(2,226,853)	(2,093,952)	(1,983,944)	(1,810,093)	(1,645,271)
Total real estate investments, net	11,172,214	11,550,126	11,900,027	12,056,264	12,412,354
Cash and cash equivalents	25,699	24,668	35,904	49,941	60,961
Assets held for sale, net	8,834	57,638	151	3,579	18,893
Operating lease right-of-use assets	275,975	323,759	333,224	336,112	336,983
Investments in unconsolidated joint ventures	311,511	325,453	327,245	327,746	327,248
Other assets, net and goodwill	842,898	822,084	797,796	795,242	693,192
Total assets	$12,637,131	$13,103,728	$13,394,347	$13,568,884	$13,849,631
LIABILITIES AND STOCKHOLDERS' EQUITY
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Liabilities
Notes and bonds payable	$4,994,859	$5,227,413	$5,340,272	$5,361,699	$5,351,827
Accounts payable and accrued liabilities	211,994	204,947	196,147	155,210	244,033
Liabilities of properties held for sale	295	3,814	222	277	437
Operating lease liabilities	229,714	273,319	278,479	279,637	279,895
Financing lease liabilities	74,503	74,087	73,629	73,193	72,939
Other liabilities	202,984	211,365	219,694	232,029	218,668
Total liabilities	5,714,349	5,994,945	6,108,443	6,102,045	6,167,799
Redeemable non-controlling interests	3,868	3,195	2,487	2,000	2,014
Stockholders' equity
Preferred stock, $0.01 par value; 200,000 shares authorized	—	—	—	—	—
Common stock, $0.01 par value; 1,000,000 shares authorized	3,810	3,809	3,808	3,808	3,806
Additional paid-in capital	9,602,592	9,597,629	9,595,033	9,591,194	9,587,637
Accumulated other comprehensive (loss) income	(10,741)	17,079	9,328	(8,554)	2,140
Cumulative net income attributable to common stockholders	1,028,794	1,069,327	1,137,171	1,219,930	1,307,055
Cumulative dividends	(3,801,793)	(3,684,144)	(3,565,941)	(3,447,750)	(3,329,562)
Total stockholders' equity	6,822,662	7,003,700	7,179,399	7,358,628	7,571,076
Non-controlling interest	96,252	101,888	104,018	106,211	108,742
Total equity	6,918,914	7,105,588	7,283,417	7,464,839	7,679,818
Total liabilities and stockholders' equity	$12,637,131	$13,103,728	$13,394,347	$13,568,884	$13,849,631
HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 9
---	---
Statements of Income
---
DOLLARS IN THOUSANDS
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
---	---	---	---	---	---
Revenues
Rental income	$322,076	$333,335	$329,680	$324,093	$329,399
Interest income	4,422	4,264	4,233	4,214	4,227
Other operating	3,943	4,661	4,230	4,618	4,436
	330,441	342,260	338,143	332,925	338,062
Expenses
Property operating	121,362	131,639	125,395	122,040	117,009
General and administrative	14,609	13,396	15,464	14,935	14,417
Normalizing items 1	(1,445)	—	(275)	—	—
Normalized general and administrative	13,164	13,396	15,189	14,935	14,417
Acquisition and pursuit costs 2	301	769	669	287	92
Merger-related costs	1,414	7,450	(15,670)	4,855	10,777
Depreciation and amortization	180,049	182,989	183,193	184,479	185,275
	317,735	336,243	309,051	326,596	327,570
Other income (expense)
Interest expense before merger-related fair value	(52,387)	(55,637)	(54,780)	(52,895)	(52,464)
Merger-related fair value adjustment	(10,800)	(10,667)	(10,554)	(10,864)	(11,979)
Interest expense	(63,187)	(66,304)	(65,334)	(63,759)	(64,443)
Gain on sales of real estate properties	20,573	48,811	7,156	1,007	73,083
Gain on extinguishment of debt	—	62	—	—	119
Impairment of real estate assets and credit loss reserves	(11,403)	(56,873)	(55,215)	(31,422)	(54,452)
Equity (loss) gain from unconsolidated joint ventures	(430)	(456)	(17)	(780)	89
Interest and other income (expense), net	65	139	592	547	(1,168)
	(54,382)	(74,621)	(112,818)	(94,407)	(46,772)
Net (loss) income	$(41,676)	$(68,604)	$(83,726)	$(88,078)	$(36,280)
Net loss (income) attributable to non-controlling interests	1,143	760	967	953	516
Net (loss) income attributable to common stockholders	$(40,533)	$(67,844)	$(82,759)	$(87,125)	$(35,764)
Basic earnings per common share	$(0.11)	$(0.18)	$(0.22)	$(0.23)	$(0.10)
Diluted earnings per common share	$(0.11)	$(0.18)	$(0.22)	$(0.23)	$(0.10)
Weighted average common shares outstanding - basic	379,044	378,925	378,897	378,840	378,617
Weighted average common shares outstanding - diluted 3	379,044	378,925	378,897	378,840	378,617
STATEMENTS OF INCOME SUPPLEMENTAL INFORMATION
---	---	---	---	---	---
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Interest income
Financing receivables	$2,132	$2,002	$2,053	$2,144	$2,203
Interest on mortgage and mezzanine loans	2,290	2,262	2,180	2,070	2,024
Total	$4,422	$4,264	$4,233	$4,214	$4,227
Other operating income
Parking income	$2,392	$2,751	$2,370	$2,391	$2,413
Management fee and miscellaneous income	1,551	1,910	1,860	2,227	2,023
Total	$3,943	$4,661	$4,230	$4,618	$4,436

14Q 2023 normalizing items include severance costs and 2Q 2023 includes non-routine legal costs.

2Includes third party and travel costs related to the pursuit of acquisitions and developments.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 10
FFO, Normalized FFO, & FAD 1,2,3
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA			4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
---	---	---	---	---	---
Net (loss) income attributable to common stockholders	$(40,533)	$(67,844)	$(82,759)	$(87,125)	$(35,764)
Net loss attributable to common stockholders per diluted share 3	$(0.11)	$(0.18)	$(0.22)	$(0.23)	$(0.10)
Gain on sales of real estate assets	$(20,573)	$(48,811)	$(7,156)	$(1,007)	(73,083)
Impairments of real estate assets	11,403	56,873	55,215	26,227	54,452
Real estate depreciation and amortization	182,272	185,143	185,003	186,109	186,658
Non-controlling loss from partnership units	(491)	(841)	(1,027)	(1,067)	(382)
Unconsolidated JV depreciation and amortization	4,442	4,421	4,412	4,841	4,020
FFO adjustments	$177,053	$196,785	$236,447	$215,103	$171,665
FFO adjustments per common share - diluted	$0.46	$0.51	$0.62	$0.56	$0.45
FFO	$136,520	$128,941	$153,688	$127,978	$135,901
FFO per common share - diluted	$0.36	$0.34	$0.40	$0.33	$0.35
Acquisition and pursuit costs	301	769	669	287	92
Merger-related costs	1,414	7,450	(15,670)	4,855	10,777
Lease intangible amortization	261	213	240	146	137
Non-routine legal costs/forfeited earnest money received	(100)	—	275	—	194
Debt financing costs	—	(62)	—	—	625
Severance costs	1,445	—	—	—	—
Allowance for credit losses 4	—	—	—	8,599	—
Merger-related fair value adjustment	10,800	10,667	10,554	10,864	11,979
Unconsolidated JV normalizing items 5	89	90	93	117	96
Normalized FFO adjustments	$14,210	$19,127	$(3,839)	$24,868	$23,900
Normalized FFO adjustments per common share - diluted	$0.04	$0.05	$(0.01)	$0.06	$0.06
Normalized FFO	$150,730	$148,068	$149,849	$152,846	$159,801
Normalized FFO per common share - diluted	$0.39	$0.39	$0.39	$0.40	$0.42
Non-real estate depreciation and amortization	685	475	802	604	624
Non-cash interest amortization, net 6	1,265	1,402	1,618	682	2,284
Rent reserves, net	1,404	442	(54)	1,371	(100)
Straight-line rent income, net	(7,872)	(8,470)	(8,005)	(8,246)	(9,873)
Stock-based compensation	3,566	2,556	3,924	3,745	3,573
Unconsolidated JV non-cash items 7	(206)	(231)	(316)	(227)	(316)
Normalized FFO adjusted for non-cash items	149,572	144,242	147,818	150,775	155,993
2nd generation TI	(18,715)	(21,248)	(17,236)	(8,882)	(13,523)
Leasing commissions paid	(14,978)	(8,907)	(5,493)	(7,013)	(7,404)
Capital expenditures	(17,393)	(14,354)	(8,649)	(8,946)	(25,669)
Total maintenance capex	(51,086)	(44,509)	(31,378)	(24,841)	(46,596)
FAD	$98,486	$99,733	$116,440	$125,934	$109,397
Quarterly dividends and OP distributions	$118,897	$119,456	$119,444	$119,442	$119,323
FFO wtd avg common shares outstanding - diluted 8	383,326	383,428	383,409	383,335	383,228

3Potential common shares are not included in the computation of diluted earnings per share when a loss exists, as the effect would be an antidilutive per share amount.

5Includes the Company's proportionate share of normalizing items related to unconsolidated joint ventures such as lease intangibles and acquisition and pursuit costs.

6Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.

7Includes the Company's proportionate share of straight-line rent, net and rent reserves, net related to unconsolidated joint ventures.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 11
Capital Funding & Commitments
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
ACQUISITION AND RE/DEVELOPMENT FUNDING
---	---	---	---	---	---
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Acquisitions 1	—	11,450	—	31,500	26,388
Re/development 2	32,272	30,945	32,068	16,928	23,372
1st generation TI & acquisition capex 3	7,632	9,013	10,258	11,870	21,218
MAINTENANCE CAPITAL EXPENDITURES FUNDING
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
2nd generation TI	18,715	21,248	17,236	8,882	13,523
Leasing commissions paid	14,978	8,907	5,493	7,013	7,404
Capital expenditures	17,393	14,354	8,649	8,946	25,669
	51,086	44,509	31,378	24,841	46,596
% of Cash NOI
2nd generation TI	9.2	10.4	8.3	4.2	6.4
Leasing commissions paid	7.3	4.4	2.6	3.3	3.5
Capital expenditures	8.5	7.0	4.2	4.3	12.1
	25.0	21.8	15.1	11.8	22.0
LEASING COMMITMENTS 4
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Renewals
Square feet	582,239	625,762	638,587	949,285	623,363
2nd generation TI/square foot/lease year	1.89	1.76	1.64	1.84	1.90
Leasing commissions/square foot/lease year	1.66	1.48	1.19	0.87	0.78
Renewal commitments as a % of annual net rent	12.7	13.1	12.8	11.5	11.7
WALT (in months) 5	43.1	42.1	56.7	56.8	51.7
New leases
Square feet	315,243	344,524	205,565	274,344	297,340
2nd generation TI/square foot/lease year	5.98	5.57	7.11	4.44	6.25
Leasing commissions/square foot/lease year	1.72	1.81	1.40	0.83	1.49
New lease commitments as a % of annual net rent	33.4	32.1	45.0	21.6	36.2
WALT (in months) 5	90.2	85.8	81.3	84.7	72.7
All
Square feet	897,482	970,286	844,152	1,223,629	920,703
Leasing commitments as a % of annual net rent	21.9	22.6	21.7	14.7	21.0
WALT (in months) 5	59.6	57.6	62.7	63.1	58.4

All values are in US Dollars.

1Acquisitions include properties acquired through joint ventures at the Company's ownership percentage.

2Re/development funding includes capital spend on re/developments, development completions and unstabilized properties.

3Acquisition capex includes near-term fundings underwritten as part of recent acquisitions.

4Reflects leases commencing in the quarter. Excludes recently acquired or disposed properties, development completions, construction in progress, land held for development, corporate property, redevelopment properties, unstabilized properties, planned dispositions and assets classified as held for sale.

5WALT = weighted average lease term.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 12
Debt Metrics1
---
DOLLARS IN THOUSANDS
SUMMARY OF INDEBTEDNESS AS OF DECEMBER 31, 2023
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
	PRINCIPAL BALANCE	BALANCE 1	MATURITY DATE		MONTHS TO MATURITY 2		INTEREST EXPENSE	CONTRACTUAL INTEREST EXPENSE	CONTRACTUAL RATE			EFFECTIVE RATE			FAIR VALUE MERGER ADJUSTED
SENIOR NOTES	250,000	249,484	5/1/2025		16		2,470	2,422	3.88		%	4.12		%
				31		7,142			%	4.94		%	Y
				42		5,750			%	4.76		%	Y
				49		2,783			%	3.85		%
				74		7,598			%	5.30		%	Y
				75		1,928			%	2.72		%
				87		1,591			%	2.25		%
				87		8,288			%	5.13		%	Y
	3,699,285	3,427,233			59		37,550	27,448	2.97		%	4.43		%
TERM LOANS	350,000	349,798	7/20/2025		19		5,703	5,703	SOFR + 1.05%			6.39		%
				29		3,259				6.39		%
				29		2,445				6.39		%
				34		4,888				6.39		%
				42		3,259				6.39		%
				48		4,888				6.39		%
	1,500,000	1,497,092			33		24,442	24,442				6.39		%
1.5B CREDIT FACILITY	0	0	10/31/2027		46		3,892	3,892	SOFR + 0.95%			6.31		%
MORTGAGES	70,752	70,534	various		19		754	791	4.17		%	4.15		%
	5,270,037	4,994,859			49		66,638	56,573	3.96		%	5.02		%	$2,550,000
Interest rate swaps							(5,763)	(5,763)
Interest cost capitalization							(884)	—
Unsecured credit facility fee & deferred financing costs							1,265	946
Amortization of fair value of swap maturing January 2024							997	—	1.21		%	3.21		%	Y
Financing right-of-use asset amortization							934	—
							63,187	51,756

All values are in US Dollars.

DEBT MATURITIES SCHEDULE AS OF DECEMBER 31, 2023
	PRINCIPAL PAYMENTS
	BANK <br>LOANS	SENIOR NOTES	TOTAL
2024			25,473	%
2025	$350,000	250,000	616,375	%
2026	$650,000	600,000	1,278,904	%
2027	200,000	500,000	700,000	%
2028	300,000	300,000	600,000	%
Thereafter		2,049,285	2,049,285	%
Total	$1,500,000	3,699,285	5,270,037	%
Fixed rate debt balance 3	$1,075,000	3,699,285	4,845,037
% fixed rate debt to net debt 3
Company share of JV net debt		24,284

All values are in US Dollars.

INTEREST RATE SWAPS
MATURITY	AMOUNT	FIXED SOFR RATE
January 2024	200,000	1.21	%
May 2026	275,000	3.74	%
June 2026	150,000	3.83	%
December 2026	150,000	3.84	%
June 2027	200,000	4.27	%
December 2027	300,000	3.93	%
As of 12/31/2023	$1,275,000	3.49	%
Subsequent activity:
Expiring Jan 2024	(200,000)	(1.21	%)
As of 2/1/2024	$1,075,000	3.92	%

1Balances are reflected net of discounts, fair value adjustments, and deferred financing costs and include premiums.

2Includes extension options.

3Fixed rate debt balance includes the impact of the January 2024 expiring interest rate swap.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 13
Debt Covenants & Liquidity
---
DOLLARS IN THOUSANDS
SELECTED FINANCIAL DEBT COVENANTS YEAR ENDED DECEMBER 31, 2023 1
---	---	---	---	---
	CALCULATION	REQUIREMENT	PER DEBT COVENANTS
Revolving credit facility and term loan
Leverage ratio	Total debt/total capital	Not greater than 60%	37.5	%
Secured leverage ratio	Total secured debt/total capital	Not greater than 30%	0.5	%
Unencumbered leverage ratio	Unsecured debt/unsecured real estate	Not greater than 60%	40.0	%
Fixed charge coverage ratio	EBITDA/fixed charges	Not less than 1.50x	3.1x
Unsecured coverage ratio	Unsecured EBITDA/unsecured interest	Not less than 1.75x	3.1x
Asset investments	Unimproved land, JVs & mortgages/total assets	Not greater than 35%	8.3	%
Senior Notes
Incurrence of total debt	Total debt/total assets	Not greater than 60%	37.5	%
Incurrence of debt secured by any lien	Secured debt/total assets	Not greater than 40%	0.5	%
Maintenance of total unsecured assets	Unencumbered assets/unsecured debt	Not less than 150%	263.9	%
Debt service coverage	EBITDA/interest expense	Not less than 1.5x	3.2x
Other
Net debt to adjusted EBITDA 2	Net debt (debt less cash)/adjusted EBITDA	Not required	6.4x
Net debt to enterprise value 3	Net debt/enterprise value	Not required	44.2	%
LIQUIDITY SOURCES
---	---
Cash	$25,699
Unsecured credit facility availability	1,500,000
Consolidated unencumbered assets (gross) 4	13,216,513

1Does not include all financial and non-financial covenants and restrictions that are required by the Company's various debt agreements. Financial measures include the Company's proportionate share of unconsolidated joint ventures, as applicable.

2Net debt includes the Company's share of unconsolidated JV net debt. See page 25 for a reconciliation of adjusted EBITDA.

3Based on the closing price of $17.23 on December 29, 2023 and 384,816,882 shares outstanding including outstanding OP units.

4Annualized fourth quarter 2023 unencumbered asset NOI was $797.1 million.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 14
Investment Activity
---
DOLLARS IN THOUSANDS
MOB ACQUISITION ACTIVITY
---	---	---	---	---	---	---	---	---	---	---
MARKET	COUNT	MILES TO CAMPUS	ASSOCIATED HEALTH SYSTEM	CLOSING	SQUARE<br>FEET	LEASED %		PURCHASEPRICE 1	% OWNERSHIP
Tampa, FL	1	0.06	BayCare Health	3/10/2023	115,867	98	%	31,500	100	%
Colorado Springs, CO	1	1.30	UC Health	7/28/2023	42,770	94	%	11,450	100	%
Total	2				158,637	97	%	42,950	100	%
Average cap rate 2								6.5

All values are in US Dollars.

DISPOSITIONS TO REPAY ASSET SALE TERM LOAN
LOCATION	TYPE	CLOSING	SQUARE FEET	LEASED %		SALE <br>PRICE
Tampa, FL & Miami, FL 3	MOB	1/12/2023	224,037	100	%	$93,250
Dallas, TX 4	INPATIENT	1/30/2023	36,691	100	%	19,210
Total			260,728	100	%	$112,460
ADDITIONAL DISPOSITION ACTIVITY
LOCATION	TYPE	CLOSING	SQUARE FEET	LEASED %		SALE <br>PRICE
St. Louis, MO	MOB	2/10/2023	6,500	100	%	$350
Los Angeles, CA	MOB	3/23/2023	37,165	100	%	21,000
Los Angeles, CA 5	MOB	3/30/2023	147,078	99	%	75,000
Los Angeles, CA 6	LAND	5/12/2023	-	—	%	3,300
Albany, NY	MOB	6/30/2023	40,870	96	%	10,000
Houston, TX	OFFICE	8/2/2023	57,170	88	%	8,320
Atlanta, GA	MOB	8/22/2023	55,195	100	%	25,140
Dallas, TX	INPATIENT	9/15/2023	161,264	100	%	115,000
Houston, TX	MOB	9/18/2023	52,040	—	%	250
Chicago, IL	MOB	9/27/2023	104,912	100	%	59,950
Evansville, IN 7	MOB	11/13/2023	260,520	100	%	18,550
Houston, TX	HOSPITAL	12/1/2023	83,223	—	%	3,900
Charleston, SC 8	OFFICE	12/15/2023	15,014	100	%	5,760
Dallas, TX	MOB	12/20/2023	77,827	100	%	41,640
Los Angeles, CA	OFFICE	12/21/2023	104,377	—	%	17,830
Tucson, AZ 9,10	MOB	12/22/2023	215,471	72	%	38,990
Miami, FL	MOB	12/22/2023	48,000	91	%	17,330
Sebring, FL	MOB	12/27/2023	38,949	100	%	9,420
Boston, MA	MOB	12/28/2023	161,254	100	%	114,770
Jacksonville/Orlando/Miami, FL 11,12	SNF	12/29/2023	354,500	100	%	69,730
Total			2,021,329	84	%	$656,230
Average cap rate 13				6.6	%

1Includes joint venture acquisitions at full acquisition price.

2For acquisitions, cap rate represents the forecasted first year NOI divided by purchase price. Does not include fees earned related to the unconsolidated joint venture.

3Includes two properties, sold in two separate transactions to the same buyer on the same date.

4Values and square feet are represented at 100%. The Company retained a 40% ownership interest in the joint venture that purchased this property.

5The Company entered into a mortgage note agreement with the buyer for $45.0 million.

6The Company sold a land parcel totaling 0.34 acres.

7Includes five properties, sold in three separate transactions to the same buyer on the same date.

8The Company sold a corporate office in Charleston, SC that was 100% leased by the Company.

9Includes 12 properties, sold in one transaction to the same buyer.

10The Company entered into a mortgage note agreement with the buyer for $6.0 million.

11Includes three properties, sold in one transaction to the same buyer.

12The Company entered into a mortgage note agreement with the buyer for $7.7 million.

13For dispositions, cap rate represents the in-place cash NOI divided by sales price.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 15
Re/development Activity
---
DOLLARS IN THOUSANDS
RE/DEVELOPMENT PROJECTS
---	---	---	---	---	---	---
MARKET	ASSOCIATED HEALTH SYSTEM		SQUARE<br>FEET		CURRENT LEASED %	BUDGET
Active development
Nashville, TN	Ascension		106,194		50	44,000
Orlando, FL 1	Advent Health		156,566		78	65,000
Raleigh, NC	UNC REX Health		120,694		42	52,600
Phoenix, AZ	HonorHealth		101,000		80	54,000
Total development			484,454		63	215,600
Projected stabilized yield - 6.5%-8.0%
Estimated stabilization period post completion - 12 - 36 months
Active redevelopment
Washington, DC	Inova Health		259,290		85	21,200
Houston, TX	HCA		314,861		61	30,000
Charlotte, NC	Novant Health		169,135		54	18,700
Washington, DC	Inova Health		57,323		67	10,078
Total redevelopment			800,609		68	79,978
Occupied %					63
Projected stabilized yield - 9.0%-12.0%
Estimated stabilization period post completion - 12 - 36 months
Total active re/development projects		1,285,063	66	%	295,578	145,703

All values are in US Dollars.

1Investment is a construction loan with purchase rights upon completion.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 16
Portfolio 1,2
---
DOLLARS IN THOUSANDS
MARKETS
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
		WHOLLY OWNED COUNT		SQUARE FEET										WHOLLY OWNED
MARKET	MSA RANK		MOB		INPATIENT				WHOLLY OWNED				TOTAL		% OF NOI		CUMULATIVE % OF NOI
Dallas, TX	4	43		3,230,488		146,519		199,800		3,576,807		226,076		3,802,883		8.9		%	8.9	%
Seattle, WA	15	29		1,592,501						1,592,501				1,592,501		6.3		%	15.2	%
Houston, TX	5	31		2,351,135		67,500				2,418,635				2,418,635		4.6		%	19.8	%
Denver, CO	19	33		1,780,819				93,869		1,874,688		116,616		1,991,304		4.4		%	24.2	%
Charlotte, NC	22	32		1,792,908						1,792,908				1,792,908		4.3		%	28.5	%
Los Angeles, CA	2	20		1,034,336		63,000				1,097,336		702,453		1,799,789		4.1		%	32.6	%
Atlanta, GA	9	27		1,423,141						1,423,141				1,423,141		3.9		%	36.5	%
Boston, MA	11	17		806,410						806,410				806,410		3.6		%	40.1	%
Miami, FL	7	18		1,196,531						1,196,531				1,196,531		3.2		%	43.3	%
Nashville, TN	36	13		1,241,872				108,691		1,350,563				1,350,563		3.0		%	46.3	%
Raleigh, NC	42	28		1,109,582						1,109,582				1,109,582		2.9		%	49.2	%
Phoenix, AZ	10	35		1,512,304						1,512,304				1,512,304		2.9		%	52.1	%
Austin, TX	29	13		863,700						863,700				863,700		2.6		%	54.7	%
Tampa. FL	18	19		971,975						971,975				971,975		2.6		%	57.3	%
Indianapolis, IN	33	40		1,162,955		61,398				1,224,353		273,479		1,497,832		2.5		%	59.8	%
New York, NY	1	15		704,415						704,415				704,415		2.1		%	61.9	%
San Francisco, CA	12	6		452,666						452,666		110,865		563,531		1.9		%	63.8	%
Memphis, TN	43	11		802,221		54,416				856,637				856,637		1.9		%	65.7	%
Chicago, IL	3	6		607,845						607,845				607,845		1.9		%	67.6	%
Honolulu, HI	56	6		439,500						439,500				439,500		1.8		%	69.4	%
Other (49 markets)		212		10,719,447		540,974		1,228,363		12,488,784		519,911		13,008,695		30.6		%	100.0	%
Total		654		35,796,751		933,807		1,630,723		38,361,281		1,949,400		40,310,681		100.0		%
Number of properties				631		15		8		654		34		688
% of square feet				93.3		2.4	%	4.3		100.0	%
% multi-tenant				85.8		—	%	64.3		82.8	%
Investment				12,244,036		439,464		467,182		13,150,683
Quarterly cash NOI 1				179,830		8,181		6,442		194,453
% of cash NOI				92.5		4.2	%	3.3		100.0	%

All values are in US Dollars.

BY OWNERSHIP AND TENANT TYPE
	WHOLLY OWNED		JOINT VENTURES3
	MULTI-TENANT	SINGLE-TENANT		MULTI-TENANT	SINGLE-TENANT	TOTAL
Number of properties	528	126		24	10	688
Square feet	31,776,412	6,584,869		1,594,634	354,766	40,310,681
% of square feet	78.8	16.3		4.0	0.9	100.0
Investment 1	10,407,242	2,743,441		276,127	83,510	13,510,320
Quarterly cash NOI 1	151,160	43,292		3,503	1,255	199,210
% of cash NOI	75.9	21.7		1.8	0.6	100.0

All values are in US Dollars.

1Gross investment and quarterly cash NOI are reflected at the Company's ownership percentage.

2Excludes assets held for sale, land held for development, construction in progress and corporate property.

3The Company's weighted average ownership percentage in its joint ventures was approximately 44%.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 17
Health Systems 1
---		MOB PORTFOLIO
---	---	---	---	---	---	---	---	---	---	---	---	---	---
			BUILDING SQUARE FEET			# OF BLDGS				LEASED BY HEALTH SYSTEM	% OF LEASED SF		# OF LEASES
HEALTH SYSTEM	SYSTEM RANK 2	CREDIT RATING	ON/ADJACENT 3	OFF-CAMPUS AFFILIATED 4	TOTAL		% OF NOI
HCA	1	BBB-/Baa3	2,267,969	779,288	3,047,257	46		8.9	%	786,142	2.5	%	133
CommonSpirit	4	A-/Baa1	1,953,665	636,320	2,589,985	45		7.1	%	909,512	2.9	%	164
Baylor Scott & White	21	AA-/Aa3	2,570,180	66,376	2,636,556	29		6.8	%	1,266,687	4.1	%	193
Ascension Health	3	AA+/Aa2	2,262,563	97,551	2,360,114	25		5.8	%	929,333	3.0	%	145
Advocate Health	14	AA/Aa3	790,317	496,198	1,286,515	20		4.1	%	1,128,837	3.6	%	96
Tenet Healthcare Corporation	6	B+/B1	1,216,425	376,410	1,592,835	26		3.7	%	396,589	1.3	%	83
Wellstar Health System	75	A+/A2	896,773	23,088	919,861	18		2.8	%	582,754	1.9	%	81
UW Medicine (Seattle)	91	AA+/Aaa	461,363	169,709	631,072	10		2.7	%	294,971	0.9	%	32
AdventHealth	11	AA/Aa2	758,638	118,585	877,223	13		2.6	%	372,649	1.2	%	78
Baptist Memorial Health Care	89	A-2/--	544,122	252,414	796,536	10		2.1	%	430,579	1.4	%	57
Community Health Systems	8	CCC+/Caa2	785,169	—	785,169	16		2.0	%	353,558	1.1	%	45
Providence St. Joseph Health	5	A/A2	330,287	31,601	361,888	8		1.7	%	137,032	0.4	%	25
Cedars-Sinai Health Systems	51	AA-/Aa3	199,701	90,607	290,308	5		1.6	%	65,278	0.2	%	21
Trinity Health	7	AA-/Aa3	678,920	22,956	701,876	11		1.6	%	354,279	1.1	%	54
Hawaii Pacific Health	181	--/A1	173,502	124,925	298,427	3		1.5	%	98,398	0.3	%	39
Banner Health	24	AA-/--	749,075	31,039	780,114	24		1.4	%	134,107	0.4	%	34
WakeMed	185	--/A2	373,980	101,597	475,577	13		1.4	%	144,265	0.5	%	21
Bon Secours Health System	22	A+/A2	405,945	—	405,945	6		1.3	%	242,817	0.8	%	50
Overlake Health System	291	BBB+/Baa1	230,710	—	230,710	3		1.2	%	73,676	0.2	%	8
UNC Health Care	62	A+/Aa3	273,186	84,886	358,072	8		1.1	%	219,400	0.7	%	27
Sutter Health	12	A+/A1	175,591	76,507	252,098	3		1.1	%	93,229	0.3	%	19
Other (70 credit rated)			6,377,613	3,390,143	9,767,756	191		25.9	%	4,153,411	13.3	%
Subtotal - credit rated 5			24,475,694	6,970,200	31,445,894	533		88.4	%	13,167,503	42.1	%
Other non-credit rated 6			1,319,416	612,886	1,932,302	39		6.5	%	860,198	2.8	%
Off-campus non-affiliated 7			—	2,418,555	2,418,555	59		5.1	%	—	—	%
Wholly-owned			25,795,110	10,001,641	35,796,751	631		100.0	%	14,027,701	44.9	%
Joint ventures			1,143,456	579,868	1,723,324
Total			26,938,566	10,581,509	37,520,075

1Excludes construction in progress and assets classified as held for sale.

2Ranked by revenue based on Modern Healthcare's Healthcare Systems Financials Database.

3The Company defines an adjacent property as being no more than 0.25 miles from a hospital campus.

4Includes off-campus buildings where health systems lease 20% or more of the property and/or are located within 2 miles from a hospital campus.

5Based on square footage, 80% is associated and 40% is leased by an investment-grade rated healthcare provider.

6Includes 40 properties associated with hospital systems that are not credit rated.

7Includes off-campus buildings that are not 20% or more leased by a health system and are more than two miles from a hospital campus.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 18
MOB Proximity to Hospital 1,2
---		MOB BY LOCATION
---	---	---	---	---	---	---
	# OF PROPERTIES	SQUARE FEET	TOTAL		% GROUND LEASED
On campus	235	18,176,920	48.4	%	37.3	%
Adjacent to campus 3	186	8,761,646	23.4	%	3.5	%
Total on/adjacent	421	26,938,566	71.8	%	40.8	%
Off campus - affiliated 4	175	8,029,593	21.4	%	3.7	%
Off campus	62	2,551,916	6.8	%	0.6	%
	658	37,520,075	100.0	%	45.1	%
Wholly-owned	631	35,796,751
Joint ventures	27	1,723,324
MOB BY CLUSTER 5
---	---	---	---	---	---	---	---	---
	TOTAL				HOSPITAL CENTRIC 6
	# OF PROPERTIES	SQUARE FEET	% OF MOB SQUARE FEET		# OF PROPERTIES	SQUARE FEET	% OF MOB SQUARE FEET
Clustered	474	26,248,018	70.0	%	391	22,899,795	72.3	%
Non-clustered	184	11,272,057	30.0	%	126	8,758,455	27.7	%
Total	658	37,520,075	100.0	%	517	31,658,250	100.0	%

1Includes joint venture properties and excludes construction in progress and assets classified as held for sale.

2Proximity to hospital campus includes acute care hospitals with inpatient beds. The Company does not consider inpatient rehab hospitals (IRFs), skilled nursing facilities (SNFs) or long-term acute care hospitals (LTACHs) to be hospital campuses for distance calculations.

3The Company defines an adjacent property as being no more than 0.25 miles from a hospital campus.

4Includes off-campus buildings where health systems lease 20% or more of the property and/or are located within 2 miles from a hospital campus.

5A cluster is defined as at least two properties within a geographic radius of two miles. The Company believes clusters provide operational efficiencies and greater local leasing knowledge that accelerate NOI growth.

6Includes buildings that are located within two miles of a hospital campus.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 19
Lease Maturity & Occupancy1
---
LEASE MATURITY SCHEDULE
---	---	---	---	---	---	---	---	---	---	---	---	---	---
		SQUARE FEET												# OF WHOLLY-OWNED LEASES
		WHOLLY-OWNED AND JOINT VENTURE
		MULTI-TENANT 2		SINGLE-TENANT		TOTAL		% OF TOTAL		JOINT VENTURES		WHOLLY-OWNED
Month-to-month		412,192		3,589		415,781		1.2	%	24,104		391,677		188
Q1 2024		1,538,828		498,970		2,037,798		5.8	%	25,140		2,012,658		430
Q2 2024		1,068,131		78,584		1,146,715		3.3	%	55,305		1,091,410		348
Q3 2024		1,098,420		456,522		1,554,942		4.4	%	111,398		1,443,544		345
Q4 2024		1,044,123		104,517		1,148,640		3.3	%	28,977		1,119,663		296
2025		3,807,315		956,710		4,764,025		13.5	%	179,899		4,584,126		1,097
2026		3,898,898		304,579		4,203,477		11.9	%	122,587		4,080,890		1,059
2027		3,346,972		999,428		4,346,400		12.3	%	152,639		4,193,761		853
2028		3,128,365		709,194		3,837,559		10.9	%	106,363		3,731,196		834
2029		1,767,614		616,449		2,384,063		6.8	%	342,627		2,041,436		400
2030		1,859,314		756,694		2,616,008		7.4	%	87,788		2,528,220		366
2031		1,090,010		137,827		1,227,837		3.5	%	29,760		1,198,077		252
2032		1,840,390		361,573		2,201,963		6.2	%	62,415		2,139,548		295
2033		955,127		207,370		1,162,497		3.3	%	40,812		1,121,685		202
Thereafter		1,592,872		628,928		2,221,800		6.2	%	311,401		1,910,399		204
Total occupied		28,448,571		6,820,934		35,269,505		87.5	%	1,681,215		33,588,290		7,169
Total building		33,371,046		6,939,635		40,310,681				1,949,400		38,361,281
Occupancy		85.2	%	98.3	%	87.5	%			86.2	%	87.6	%
Leased %		87.3	%	98.3	%	89.2	%			86.7	%	89.3	%
WALTR (months) 3	49.3	62.6		51.9						50.5
WALT (months) 3	95.7	137.2		103.7						102.0
LEASING ACTIVITY
---	---
	Q4 2023
	ABSORPTION ACTIVITY	SQUARE FEET
Occupied square feet, beginning of period		35,929,113
Dispositions		(837,582)
Expirations and early vacates	(1,045,118)
Renewals, amendments and extensions	702,550
New lease commencements	520,542
Absorption		177,974
Occupied square feet, end of period		35,269,505

1Excludes land held for development, construction in progress, corporate property and assets classified as held for sale, unless noted otherwise.

2The average lease size in the wholly-owned multi-tenant portfolio is 3,956 square feet.

3WALTR = weighted average lease term remaining; WALT = weighted average lease term.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 20
Leasing Statistics
---
MERGER COMBINED SAME STORE RENEWALS 1
---	---	---	---	---
	Q4 2023		TTM
MOB cash leasing spreads 2	3.3	%	3.5	%
MOB cash leasing spreads distribution
< 0% spread	3.0	%	4.7	%
0-3% spread	5.5	%	12.9	%
3-4% spread	75.6	%	64.9	%
> 4% spread	15.9	%	17.5	%
Total	100.0	%	100.0	%
Tenant retention rate	78.2	%	79.3	%
AVERAGE IN-PLACE CONTRACTUAL INCREASES 3
---	---	---	---	---	---	---	---	---	---	---	---	---
	MULTI-TENANT				SINGLE-TENANT				TOTAL
	% INCREASE		% OF <br>BASE RENT		% INCREASE		% OF <br>BASE RENT		% INCREASE		% OF <br>BASE RENT
Merger combined same store 1	2.88	%	70.3	%	2.52	%	17.9	%	2.81	%	88.3	%
Acquisitions	2.77	%	2.8	%	4.19	%	0.5	%	2.98	%	3.2	%
Other 4	2.74	%	7.0	%	2.21	%	1.5	%	2.65	%	8.5	%
Total	2.87	%	80.1	%	2.54	%	19.9	%	2.81	%	100.0	%
Escalator type
Fixed	2.82	%	96.7	%	2.53	%	89.0	%	2.76	%	95.2	%
CPI	4.27	%	3.3	%	2.62	%	11.0	%	3.52	%	4.8	%
TYPE AND OWNERSHIP STRUCTURE 1
---	---	---	---	---	---	---
	MULTI-TENANT		SINGLE-TENANT		TOTAL
Tenant type
Hospital	46.7	%	71.5	%	51.7	%
Physician and other	53.3	%	28.5	%	48.3	%
Lease structure
Gross	9.0	%	2.9	%	7.8	%
Modified gross	31.5	%	11.2	%	27.5	%
Net	59.5	%	63.7	%	60.4	%
Absolute net 5	—	%	22.2	%	4.3	%
Ownership type
Ground lease	44.1	%	38.7	%	43.2	%
Fee simple	55.9	%	61.3	%	56.8	%
# OF LEASES BY SIZE 6
---	---	---	---
LEASED SQUARE FEET	# OF LEASES	WALT	WALTR
0 - 2,500	3,653	71.4	36.4
2,501 - 5,000	1,813	82.7	41.2
5,001 - 7,500	633	92.9	46.5
7,501 - 10,000	362	97.9	50.8
10,001 +	708	121.4	59.2
Total Leases	7,169	102.0	50.5

1Excludes recently acquired or disposed properties, construction in progress, land held for development, corporate property, planned dispositions and assets classified as held for sale.

2Excludes non-MOB renewals of 44,000 square feet and 98,000 square feet for the fourth quarter and trailing twelve months, respectively.

3Excludes leases with lease terms of one year or less.

4Includes redevelopment properties, development completion, and joint ventures.

5Tenant is typically responsible for operating expenses and capital obligations.

6Excludes joint ventures, land held for development, construction in progress, corporate property and assets classified as held for sale.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 21
Merger Combined Same Store1
---
DOLLARS IN THOUSANDS, EXCEPT PER SQUARE FOOT DATA
REFLECTS COMBINED COMPANY RESULTS FOR ALL PERIODS
TOTAL MERGER COMBINED CASH NOI
---	---	---	---	---	---	---	---	---	---	---	---
	% of Total NOI		4Q 2023	3Q 2023	4Q 2022	Y-o-Y% CHANGE		2023	2022	% CHANGE
Multi-tenant	70	%				3.2	%			2.9	%
Single-tenant	21	%	42,369	42,542	42,005	0.9	%	168,401	165,150	2.0	%
Joint venture	2	%	3,082	2,978	2,921	5.5	%	12,150	11,523	5.4	%
Merger combined same store	92	%				2.7	%			2.8	%
Planned dispositions	—	%	117	(101)	636	(81.6	%)	434	3,616	(88.0	%)
Re/development	1	%	2,664	2,116	3,187	(16.4	%)	10,071	14,254	(29.3	%)
Wholly owned and joint venture acquisitions	4	%	7,724	8,478	6,674	15.7	%	31,925	17,067	87.1	%
Development completions	1	%	1,301	1,257	817	59.2	%	4,438	2,830	56.8	%
Completed dispositions & assets held for sale	2	%	4,860	9,327	17,880	(72.8	%)	40,414	101,663	(60.2	%)
Merger combined total cash NOI	100	%	204,071	204,723	211,635	(3.6	%)	826,006	858,338	(3.8	%)

All values are in US Dollars.

PORTFOLIO OCCUPANCY AND ABSORPTION
			OCCUPANCY %						ABSORPTION<br>(square feet in thousands)
	COUNT	SQUARE FEET	4Q 2023		3Q 2023		4Q 2022		SEQUENTIAL	Y-O-Y
Multi-tenant	479	28,932,961	86.9	%	86.7	%	86.7	%	77	66
Single-tenant	118	6,364,953	99.6	%	99.6	%	99.4	%	3	15
Joint venture	18	1,225,320	87.3	%	88.5	%	88.0	%	(15)	(9)
Merger combined same store	615	36,523,234	89.2	%	89.0	%	89.0	%	65	72
Planned dispositions	5	227,686	25.5	%	26.1	%	49.7	%	(1)	(55)
Re/development	16	1,368,720	54.8	%	51.1	%	58.7	%	50	(53)
Wholly owned and joint venture acquisitions	47	1,788,173	90.9	%	90.3	%	87.7	%	11	45
Development completions	5	402,868	67.1	%	73.2	%	66.6	%	53	73
Total portfolio	688	40,310,681	87.5	%	87.3	%	87.5	%	178	82
Joint ventures	34	1,949,400	86.2	%	86.9	%	85.4	%	(14)	12
Total wholly-owned	654	38,361,281	87.6	%	87.3	%	87.6	%	192	70

1Same store properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, same store properties exclude properties that were recently acquired or disposed of, properties classified as held for sale or intended for sale, properties undergoing redevelopment, and newly redeveloped or developed properties. Legacy HTA properties that met the same store criteria are included in both periods shown as if they were owned by the Company for the full analysis period.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 22
Merger Combined Same Store1, 2
---
DOLLARS IN THOUSANDS, EXCEPT PER SQUARE FOOT DATA
REFLECTS COMBINED COMPANY RESULTS FOR ALL PERIODS
MERGER COMBINED SAME STORE CASH NOI
---	---	---	---	---	---	---	---
	TOTAL
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022	2023	2022
Base revenue	224,025	222,137	221,530	219,890	218,534	887,582	865,819
Op. exp. recoveries	68,843	73,739	68,626	69,063	65,256	280,271	264,682
Revenues	292,868	295,876	290,156	288,953	283,790	1,167,853	1,130,501
Expenses	105,463	112,230	105,709	105,727	101,349	429,129	411,593
Cash NOI	187,405	183,646	184,447	183,226	182,441	738,724	718,908
Revenue per occ SF 3	36.01	36.40	35.68	35.55	34.96	35.91	34.87
Margin	64.0	62.1	63.6	63.4	64.3	63.3	63.6
Average occupancy	89.1	89.0	89.1	89.0	88.9	89.1	88.8
Period end occupancy	89.2	89.0	89.1	89.1	89.0	89.2	89.0
Number of properties	615	615	615	615	615	615	615
Year-Over-Year Change
Revenue per occ SF 3	3.0					3.0
Avg occupancy (bps)	+20					+30
Revenues	3.2					3.3
Base revenue	2.5					2.5
Exp recoveries	5.5					5.9
Expenses	4.1					4.3
Cash NOI	2.7					2.8

All values are in US Dollars.

2Excludes recently acquired or disposed properties, development completions, construction in progress, land held for development, corporate property, redevelopment properties, planned dispositions and assets classified as held for sale.

3Revenue per occ SF is calculated by dividing revenue by the average of the occupied SF for the period provided. Quarterly revenue per occ SF is annualized.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 23
NOI Reconciliations
---
DOLLARS IN THOUSANDS		BOTTOM UP RECONCILIATION
---	---	---	---	---	---	---	---	---
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022	3Q 2022	2Q 2022	1Q 2022
Net income (loss) attr. to common stockholders	($40,533)	($67,844)	($82,759)	($87,125)	($35,764)	$28,304	$6,130	$42,227
Other income (expense)	54,382	74,621	112,818	94,407	46,772	(89,477)	7,479	(29,293)
General and administrative expense	14,609	13,396	15,464	14,935	14,417	16,741	10,540	11,036
Depreciation and amortization expense	180,049	182,989	183,193	184,479	185,275	158,117	55,731	54,041
Other expenses 1	4,899	11,783	(11,969)	7,940	13,580	82,659	11,034	9,929
Straight-line rent expense	1,484	1,538	1,525	1,537	1,358	1,260	378	378
Straight-line rent revenue	(9,356)	(10,008)	(9,530)	(9,782)	(11,231)	(8,975)	(1,705)	(1,587)
Other revenue 2	(6,221)	(6,446)	(5,959)	(1,686)	(7,330)	(5,242)	(1,961)	(2,044)
Joint venture property cash NOI	4,758	4,692	4,957	4,769	4,579	3,877	2,551	2,052
Cash NOI	$204,071	$204,721	$207,740	$209,474	$211,656	$187,264	$90,177	$86,739
Pre-merger Legacy HTA NOI	—	—	—	—	—	27,114	128,025	127,363
Cash NOI including pre-merger Legacy HTA NOI	$204,071	$204,721	$207,740	$209,474	$211,656	$214,378	$218,202	$214,102
Planned dispositions	(117)	101	126	(544)	(636)	(604)	(1,144)	(1,232)
Redevelopment	(2,664)	(2,116)	(2,455)	(2,836)	(3,187)	(3,510)	(3,605)	(3,952)
Wholly owned and joint venture acquisitions	(7,724)	(8,478)	(8,146)	(7,577)	(6,674)	(5,489)	(4,210)	(694)
Development completions	(1,301)	(1,257)	(1,021)	(859)	(817)	(682)	(528)	(803)
Completed dispositions & assets held for sale	(4,860)	(9,325)	(11,797)	(14,432)	(17,901)	(24,573)	(28,584)	(30,605)
Merger combined same store cash NOI	$187,405	$183,646	$184,447	$183,226	$182,441	$179,520	$180,131	$176,816
Same store joint venture properties	(3,082)	(2,978)	(3,125)	(2,965)	(2,921)	(2,777)	(2,917)	(2,908)
Merger combined same store excluding JVs	$184,323	$180,668	$181,322	$180,261	$179,520	$176,743	$177,214	$173,908
TOP DOWN RECONCILIATION
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022	3Q 2022	2Q 2022	1Q 2022
Rental income before rent concessions	$325,772	$336,503	$332,992	$328,115	$332,652	$301,692	$142,073	$139,775
Rent concessions	(3,696)	(3,168)	(3,312)	(4,022)	(3,253)	(2,761)	(1,441)	(1,286)
Rental income	322,076	333,335	329,680	324,093	329,399	298,931	140,632	138,489
Parking income	2,392	2,751	2,370	2,391	2,413	2,428	1,919	1,753
Interest from financing receivable, net	2,132	2,002	2,180	2,227	2,284	2,034	1,957	1,930
Exclude straight-line rent revenue	(9,356)	(10,008)	(9,530)	(9,782)	(11,231)	(8,975)	(1,705)	(1,587)
Exclude other non-cash revenue 3	(1,513)	(1,410)	(1,018)	3,594	(3,059)	(2,280)	(1,142)	(1,322)
Cash revenue	315,731	326,670	323,682	322,523	319,806	292,138	141,661	139,263
Property operating expense	(121,362)	(131,639)	(125,395)	(122,040)	(117,009)	(112,473)	(57,010)	(57,464)
Exclude non-cash expenses 4	4,668	5,079	4,556	4,336	3,764	4,034	2,975	2,888
Non-controlling interest	276	(81)	(60)	(114)	516	(312)	—	—
Joint venture property cash NOI	4,758	4,692	4,957	4,769	4,579	3,877	2,551	2,052
Cash NOI	$204,071	$204,721	$207,740	$209,474	$211,656	$187,264	$90,177	$86,739
Pre-merger Legacy HTA NOI	—	—	—	—	—	27,114	128,025	127,363
Cash NOI including pre-merger Legacy HTA NOI	$204,071	$204,721	$207,740	$209,474	$211,656	$214,378	$218,202	$214,102
Planned dispositions	(117)	101	126	(544)	(636)	(604)	(1,144)	(1,232)
Redevelopment	(2,664)	(2,116)	(2,455)	(2,836)	(3,187)	(3,510)	(3,605)	(3,952)
Wholly owned and joint venture acquisitions	(7,724)	(8,478)	(8,146)	(7,577)	(6,674)	(5,489)	(4,210)	(694)
Development completions	(1,301)	(1,257)	(1,021)	(859)	(817)	(682)	(528)	(803)
Completed dispositions & assets held for sale	(4,860)	(9,325)	(11,797)	(14,432)	(17,901)	(24,573)	(28,584)	(30,605)
Merger combined same store cash NOI	$187,405	$183,646	$184,447	$183,226	$182,441	$179,520	$180,131	$176,816
Same store joint venture properties	(3,082)	(2,978)	(3,125)	(2,965)	(2,921)	(2,777)	(2,917)	(2,908)
Merger combined same store excluding JVs	$184,323	$180,668	$181,322	$180,261	$179,520	$176,743	$177,214	$173,908

1Includes acquisition and pursuit costs, merger-related costs, rent reserves, above and below market ground lease intangible amortization, leasing commission amortization, non-cash adjustments for financing receivables, and ground lease straight-line rent.

2Includes management fee income, interest, above and below market lease intangible amortization, lease inducement amortization, lease termination fees, deferred financing cost amortization and principle related to investment in financing receivable, and tenant improvement overage amortization.

3Includes above and below market intangibles, lease inducements, lease termination fees, deferred financing cost amortization, financing receivable, and TI amortization.

4Includes above and below market ground lease intangible amortization, leasing commission amortization, and ground lease straight-line rent.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 24
NOI Reconciliations
---
DOLLARS IN THOUSANDS		RECONCILIATION OF NOI TO FULL QUARTER FFO AND NORMALIZED FFO
---	---	---	---	---	---
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Cash NOI	$204,071	$204,721	$207,740	$209,474	$211,656
General and administrative expense	(14,609)	(13,396)	(15,464)	(14,935)	(14,417)
Straight-line rent	9,356	10,008	9,530	9,782	11,231
Interest and other income (expense), net	65	139	592	547	(1,168)
Management fees and other income	1,551	1,910	1,860	2,227	2,023
Note receivable interest income	2,290	2,262	2,180	1,987	1,943
Other non-cash revenue 1	2,380	2,250	1,918	(2,526)	3,059
Other non-cash expenses 2	(4,668)	(5,079)	(4,556)	(4,336)	(3,764)
Non-real estate impairment	—	—	—	(5,196)	—
Unconsolidated JV adjustments	(352)	(337)	(185)	(357)	(143)
Debt Covenant EBITDA	$200,084	$202,478	$203,615	$196,667	$210,420
Interest expense	(63,187)	(66,304)	(65,334)	(63,759)	(64,443)
Gain on extinguishment of debt	—	62	—	—	119
Acquisition and pursuit costs	(301)	(769)	(669)	(287)	(92)
Merger-related costs	(1,414)	(7,450)	15,670	(4,855)	(10,777)
Leasing commission amortization 3	3,818	3,663	3,335	3,002	2,706
Non-real estate depreciation and amortization	(1,596)	(1,509)	(1,525)	(1,372)	(1,323)
Non controlling interest	(491)	(841)	(1,027)	(1,067)	(382)
Unconsolidated JV adjustments	(393)	(389)	(377)	(351)	(327)
FFO	$136,520	$128,941	$153,688	$127,978	$135,901
Acquisition and pursuit costs	301	769	669	287	92
Merger-related costs	1,414	7,450	(15,670)	4,855	10,777
Lease intangible amortization	261	213	240	146	137
Significant non-recurring legal fees/forfeited earnest money received	(100)	—	275	—	194
Debt financing costs	—	(62)	—	—	625
Severance costs	1,445	—	—	—	—
Merger-related fair value adjustment	10,800	10,667	10,554	10,864	11,979
Allowance for credit losses	—	—	—	8,599	—
Unconsolidated JV normalizing items	89	90	93	117	96
Normalized FFO	$150,730	$148,068	$149,849	$152,846	$159,801

1Includes above and below market lease intangibles, interest income related to sales-type leases, lease inducements, lease termination fees, deferred financing cost amortization, and principle related to investment in financing receivable and TI amortization.

2Includes above and below market ground lease intangible amortization, leasing commission amortization, and ground lease straight-line rent.

3Leasing commission amortization is included in the real estate depreciation and amortization add-back for FFO.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 25
EBITDA Reconciliations
---
DOLLARS IN THOUSANDS		RECONCILIATION OF EBITDA
---	---	---	---	---	---
	4Q 2023	3Q 2023	2Q 2023	1Q 2023	4Q 2022
Net (loss) income	($40,533)	($67,844)	($82,759)	($87,125)	($35,764)
Interest expense	63,187	66,304	65,334	63,759	64,443
Depreciation and amortization	180,049	182,989	183,193	184,479	185,275
Unconsolidated JV depreciation,amortization,and interest	4,836	4,810	4,789	5,192	4,339
EBITDA	$207,539	$186,259	$170,557	$166,305	$218,293
Leasing commission amortization	3,818	3,663	3,335	3,002	2,706
Gain on sales of real estate properties	(20,573)	(48,811)	(7,156)	(1,007)	(73,083)
Impairments on real estate properties	11,403	56,873	55,215	26,227	54,452
EBITDAre 1	$202,187	$197,984	$221,951	$194,527	$202,368
EBITDA	$207,539	$186,259	$170,557	$166,305	$218,293
Acquisition and pursuit costs	301	769	669	287	92
Merger-related costs	1,414	7,450	(15,670)	4,855	10,777
Gain on sales of real estate properties	(20,573)	(48,811)	(7,156)	(1,007)	(73,083)
Impairments on real estate assets	11,403	56,873	55,215	26,227	54,452
Gain on extinguishment of debt	—	(62)	—	—	(119)
Unconsolidated JV adjustments	—	—	—	—	8
Debt Covenant EBITDA	$200,084	$202,478	$203,615	$196,667	$210,420
Leasing commission amortization	3,818	3,663	3,335	3,002	2,706
Lease intangible amortization	261	213	240	147	137
Acquisition/disposition timing impact 2	(4,155)	(2,559)	(184)	(945)	(1,704)
Stock based compensation	3,566	2,556	3,924	3,745	3,573
Allowance for credit losses 3	—	—	—	8,599	—
Rent reserves, net	1,404	442	(54)	1,371	(100)
Unconsolidated JV adjustments	89	90	93	117	96
Adjusted EBITDA	$205,067	$206,883	$210,969	$212,703	$215,128

1Earnings before interest, taxes, depreciation and amortization for real estate ("EBITDAre") is an operating performance measure adopted by NAREIT. NAREIT defines EBITDAre equal to “net income (computed in accordance with GAAP) plus interest expense, income tax expense, depreciation and amortization, impairments and minus gains on the disposition of depreciated property.”

2Adjusted to reflect quarterly EBITDA from properties acquired or disposed in the quarter.

3In Q1 2023, allowance for credit losses included a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Income and $3.4 million reserve included in “Rental Income” on the Statement of Income for previously deferred rent and straight line rent for three skilled nursing facilities.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 26
Components of Net Asset Value
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA		CASH NOI BY PROPERTY TYPE
---	---	---	---	---	---
	4Q 2023
ASSET TYPE	MERGER COMBINED SAME STORE 1	ACQ./DEV. COMPLETIONS 2	REDEVELOPMENT	TIMING/OTHER ADJUSTMENTS 3	ADJUSTED CASH NOI	ANNUALIZED ADJUSTED NOI
MOB/Outpatient	$172,831	$8,169	$2,664	$753	$184,417	$737,668
Inpatient/Surgical	8,130	856	—	—	8,986	35,944
Office	6,441	—		—	6,441	25,764
Total Cash NOI	$187,402	$9,025	$2,664	$753	$199,844	$799,376
DEVELOPMENT PROPERTIES
---	---	---	---	---
Land held for development	59,871		384,816,882
Re/development budget	295,578
	355,449
		STOCK PRICE	IMPLIED CAP RATE
		$17.23	7.2	%
OTHER ASSETS
Disposition pipeline 4	76,319	$17.44	7.1	%
Unstabilized properties 5	286,617	$13.96	8.1	%
Cash and other assets 6	429,873
	792,809
DEBT
Unsecured credit facility	—
Unsecured term loans	1,500,000
Senior notes	3,699,285
Mortgage notes payable	70,752
Company share of joint venture net debt	24,284
Remaining re/development funding	145,703
Other liabilities 7	245,574
	5,685,598

All values are in US Dollars.

1See Merger Combined Same Store schedule on pages 22 - 23 for details on Merger Combined Same Store NOI.

2Adjusted to reflect quarterly NOI from properties acquired or stabilized re/developments completed during the full eight quarter period that are not included in merger combined same store NOI.

3Timing adjustments include and management fee income of $1.3 million, offset by $0.6 million of positive NOI for unstabilized properties, which are shown in other assets.

4Includes assets held for sale and planned dispositions.

5Includes 34 properties at their gross book value. These properties were comprised of 1.2 million square feet that generated positive NOI of $0.6 million.

6Includes cash of $25.7 million, notes receivable of $173.6 million, prepaid assets of $124.1 million, accounts receivable of $63.3 million, prepaid ground leases of $19.8 million, and other investments of $6.0 million. In addition, includes the Company's occupied portion of its corporate headquarters in Nashville of $17.4 million.

7Includes only liabilities that are expected to reduce future cash or NOI and that are currently producing non-cash benefits to NOI. Included are accounts payable and accrued liabilities of $212.0 million, security deposits of $30.2 million, and deferred operating expense reimbursements of $3.4 million.

8Total shares outstanding includes OP units.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 27
Components of Expected FFO
---
DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA
	ACTUAL	EXPECTED 2024
---	---	---	---
		2023	LOW	HIGH
OPERATING METRICS
Multi-tenant absorption (bps)		20	100	150
Multi-tenant portfolio cash NOI growth		2.3	3.50	4.75
Single-tenant portfolio cash NOI growth		0.7	0.50	1.50
Merger combined same store cash NOI growth, including Company's share of JVs		2.8	2.50	3.50
Merger combined same store lease retention rate		79.3	75.0	85.0
Normalized G&A		56,684	61,000	64,000
Straight-line rent, net		32,592	30,000	34,000
CAPITAL FUNDING
Acquisitions		42,950	0.00	0.00
Dispositions		768,690	150,000	250,000
Re/development		112,213	100,000	130,000
1st generation TI and acq. capex		38,773	30,000	40,000
Maintenance capex
2nd generation TI		66,081	60,000	70,000
Leasing commissions paid		36,391	35,000	40,000
Capital expenditures		49,342	45,000	50,000
Total maintenance capex		151,814	140,000	160,000
CASH YIELD
Acquisitions		6.5	—	—
Dispositions		6.5	6.0	7.0
Development (stabilized)			6.5	8.0
Redevelopment (stabilized)			9.0	12.0
EARNINGS AND LEVERAGE
Earnings per share		(0.74)	(0.60)	(0.10)
Normalized FFO per share		1.57	1.52	1.58
Net debt to adjusted EBITDA		6.4x	6.0x	6.5x

All values are in US Dollars.

HEALTHCARE REALTY	4Q 2023 SUPPLEMENTAL INFORMATION 28